Diferencias y similitudes | 10 ENE 23

Dermatitis atópica en niños y adultos

Revisión sobre las diferencias fisiopatológicas, presentación clínica y comorbilidades de la dermatitis atópica en niños y adultos
Autor/a: Hassiel A. Ramírez-Marín | Jonathan I. Silverberg  Pediatric Dermatology. 2022;39:345353
INDICE:  1. Texto principal | 2. Texto principal
Texto principal

1. Yew YW, Thyssen JP, Silverberg JI. A systematic review and meta-analysis of the regional and age-related differences in atopic dermatitis clinical characteristics. J Am Acad Dermatol. 2019;80(2):390-401. 10.1016/J.JAAD.2018.09.035

2. Al-naqeeb J, Danner S, Fagnan LJ, et al. The burden of childhood atopic dermatitis in the primary care setting: a report from the meta-LARC consortium. J Am Board Fam Med. 2019;32(2):191-200. 10.3122/JABFM.2019.02.180225

3. Kay J, Gawkrodger DJ, Mortimer MJ, Jaron AG. The prevalence of childhood atopic eczema in a general population. J Am Acad Dermatol. 1994;30(1):35-39. 10.1016/S0190-9622(94)70004-4

4. Lee HH, Patel KR, Singam V, Rastogi S, Silverberg JI. A systematic review and meta-analysis of the prevalence and phenotype of adult-onset atopic dermatitis. J Am Acad Dermatol. 2019;80(6):1526- 1532.e7. 10.1016/J.JAAD.2018.05.1241

5. Kim JP, Chao LX, Simpson EL, Silverberg JI. Persistence of atopic dermatitis (AD): a systematic review and meta-analysis. J Am Acad Dermatol. 2016;75(4):681-687.e11. 10.1016/J.JAAD.2016.05.028

6. Yokose U, Ishikawa J, Morokuma Y, et al. The ceramide [NP]/[NS] ratio in the stratum corneum is a potential marker for skin properties and epidermal differentiation. BMC Dermatol. 2020;20(1). 10.1186/S12895-020-00102-1.

7. Renert-Yuval Y, Del Duca E, Pavel AB, et al. The molecular features of normal and atopic dermatitis skin in infants, children, adolescents, and adults. J Allergy Clin Immunol. 2021;148(1):148-163. 10.1016/J.JACI.2021.01.001

8. Seo S, Yoon WS, Cho Y, Park SH, Choung JT, Yoo Y. Leptin and atopic dermatitis in Korean elementary school children. Iran J Allergy Asthma Immunol. 2016;15(2):138-144. https://pubmed.ncbi. nlm.nih.gov/27090367/ Accessed December 17, 2021

9. Brunner PM, Israel A, Zhang N, et al. Early-onset pediatric atopic dermatitis is characterized by T H 2/T H 17/T H 22-centered inflammation and lipid alterations. J Allergy Clin Immunol. 2018;141(6):2094-2106. 10.1016/J.JACI.2018.02.040

10. Rice NE, Patel BD, Lang IA, et al. Filaggrin gene mutations are associated with asthma and eczema in later life. J Allergy Clin Immunol. 2008;122(4):834-836. 10.1016/J.JACI.2008.07.027

11. Smieszek SP, Welsh S, Xiao C, et al. Correlation of age-of-onset of atopic dermatitis with filaggrin loss-of-function variant status. Sci Rep. 2020;10(1):2721. 10.1038/S41598-020-59627-7.

12. Palmer CNA, Irvine AD, Terron-Kwiatkowski A, et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet. 2006;38(4):441-446. 10.1038/NG1767

13. Engebretsen KA, Bandier J, Kezic S, et al. Concentration of filaggrin monomers, its metabolites and corneocyte surface texture in individuals with a history of atopic dermatitis and controls. J Eur Acad Dermatol Venereol. 2018;32(5):796-804. 10.1111/JDV.14801

14. Sandilands A, Sutherland C, Irvine AD, McLean WHI. Filaggrin in the frontline: role in skin barrier function and disease. J Cell Sci. 2009;122(Pt 9):1285-1294. 10.1242/JCS.033969

15. Gao P-S, Rafaels NM, Hand T, et al. Filaggrin mutations that confer risk of atopic dermatitis confer greater risk for eczema herpeticum. J Allergy Clin Immunol. 2009;124(3) :507-513. 10.1016/J. JACI.2009.07.034

16. Margolis DJ, Apter AJ, Gupta J, et al. The persistence of atopic dermatitis and filaggrin (FLG) mutations in a US longitudinal cohort. J Allergy Clin Immunol. 2012;130(4):912-917. 10.1016/J. JACI.2012.07.008

17. Koseki R, Morii W, Noguchi E, et al. Effect of filaggrin loss-offunction mutations on atopic dermatitis in young age: a longitudinal birth cohort study. J Hum Genet. 2019;64(9):911-917. 10.1038/ S10038-019-0628-Y

18. Rupnik H, Rijavec M, Korošec P. Filaggrin loss-of-function mutations are not associated with atopic dermatitis that develops in late childhood or adulthood. Br J Dermatol. 2015;172(2):455-461. 10.1111/BJD.13477

19. O'Regan GM, Kemperman PMJH, Sandilands A, et al. Raman profiles of the stratum corneum define 3 filaggrin genotype determined atopic dermatitis endophenotypes. J Allergy Clin Immunol. 2010;126(3) :574-580. 10.1016/J.JACI.2010.04.038

20. Thyssen JP, Tang L, Husemoen LLN, et al. Filaggrin gene mutations are not associated with food and aeroallergen sensitization without concomitant atopic dermatitis in adults. J Allergy Clin Immunol. 2015;135(5):1375-1378.e1. 10.1016/J.JACI.2015.01.001

21. Esaki H, Brunner PM, Renert-Yuval Y, et al. Early-onset pediatric atopic dermatitis is T H 2 but also T H 17 polarized in skin. J Allergy Clin Immunol. 2016;138(6):1639-1651. 10.1016/J.JACI.2016.07.013

22. Guttman-Yassky E, Diaz A, Pavel AB, et al. Use of tape strips to detect immune and barrier abnormalities in the skin of children with early-onset atopic dermatitis. JAMA Dermatology. 2019;155(12):1358-1370. 10.1001/JAMADERMATOL.2019.2983

23. Hill DA, Spergel JM. The atopic march: critical evidence and clinical relevance. Ann Allergy Asthma Immunol. 2018;120(2):131-137. 10.1016/J.ANAI.2017.10.037

24. Hirota T, Nakayama T, Sato S, et al. Association study of childhood food allergy with genome-wide association studies-discovered loci of atopic dermatitis and eosinophilic esophagitis. J Allergy Clin Immunol. 2017;140(6):1713-1716. 10.1016/J.JACI.2017.05.034

25. Fölster-Holst R. Management of atopic dermatitis: are there differences between children and adults? J Eur Acad Dermatol Venereol. 2014;28(Suppl 3):5-8. 10.1111/JDV.12481

26. Brunner PM, Guttman-Yassky E, Leung DYM. The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies. J Allergy Clin Immunol. 2017;139(4S):S65-S76. 10.1016/J.JACI.2017.01.011

27. Simon AK, Hollander GA, McMichael A. Evolution of the immune system in humans from infancy to old age. Proc Biol Sci. 2015;282(1821) :20143085. 10.1098/RSPB.2014.3085

28. Mold JE, Venkatasubrahmanyam S, Burt TD, et al. Fetal and adult hematopoietic stem cells give rise to distinct T cell lineages in humans. Science. 2010;330(6011):1695-1699. 10.1126/SCIEN CE.1196509

29. Black A, Bhaumik S, Kirkman RL, Weaver CT, Randolph DA. Developmental regulation of Th17-cell capacity in human neonates. Eur J Immunol. 2012;42(2):311-319. 10.1002/EJI.20114 1847

30. Wu KG, Li TH, Chen CJ, Cheng HI, Wang TY. Correlations of serum Interleukin-16, total IgE, eosinophil cationic protein and total eosinophil counts with disease activity in children with atopic dermatitis. Int J Immunopathol Pharmacol. 2011;24(1):15-23. 10.1177/03946 3201102400103

31. Ezzat MHM, Hasan ZE, Shaheen KYA. Serum measurement of interleukin-31 (IL-31) in paediatric atopic dermatitis: elevated levels correlate with severity scoring. J Eur Acad Dermatol Venereol. 2011;25(3):334-339. 10.1111/J.1468-3083.2010.03794.X

32. Czarnowicki T, Esaki H, Gonzalez J, et al. Early pediatric atopic dermatitis shows only a cutaneous lymphocyte antigen (CLA)(+) TH2/ TH1 cell imbalance, whereas adults acquire CLA(+) TH22/TC22 cell subsets. J Allergy Clin Immunol. 2015;136(4):941-951.e3. 10.1016/J. JACI.2015.05.049

33. Kim J, Kim BE, Lee J, et al. Epidermal thymic stromal lymphopoietin predicts the development of atopic dermatitis during infancy. J Allergy Clin Immunol. 2016;137(4):1282-1285.e4. 10.1016/J. JACI.2015.12.1306

34. Czarnowicki T, He H, Canter T, et al. Evolution of pathologic T-cell subsets in patients with atopic dermatitis from infancy to adulthood. J Allergy Clin Immunol. 2020;145(1):215-228. 10.1016/J. JACI.2019.09.031

35. Zhou L, Leonard A, Pavel AB, et al. Age-specific changes in the molecular phenotype of patients with moderate-to-severe atopic dermatitis. J Allergy Clin Immunol. 2019;144(1):144-156. 10.1016/J. JACI.2019.01.015

36. Nomura T, Wu J, Kabashima K, Guttman-Yassky E. Endophenotypic variations of atopic dermatitis by age, race, and ethnicity. J Allergy Clin Immunol Pract. 2020;8(6):1840-1852. 10.1016/J.JAIP.2020.02.022

37. Tanei R. Clinical characteristics, treatments, and prognosis of atopic eczema in the elderly. J Clin Med. 2015;4(5):979-997. 10.3390/ JCM4050979

38. Tanei R, Hasegawa Y. Atopic dermatitis in older adults: a viewpoint from geriatric dermatology. Geriatr Gerontol Int. 2016;16(Suppl 1):75-86. 10.1111/GGI.12771

39. Kisich KO, Carspecken CW, Fiéve S, Boguniewicz M, Leung DYM. Defective killing of Staphylococcus aureus in atopic dermatitis is associated with reduced mobilization of human betadefensin-3. J Allergy Clin Immunol. 2008;122(1):62-68. 10.1016/J. JACI.2008.04.022

40. Brauweiler AM, Goleva E, Leung DYM. Th2 cytokines increase Staphylococcus aureus alpha toxin-induced keratinocyte death through the signal transducer and activator of transcription 6 (STAT6). J Invest Dermatol. 2014;134(8):2114-2121. 10.1038/ JID.2014.43

41. Niebuhr M, Scharonow H, Gathmann M, Mamerow D, Werfel T. Staphylococcal exotoxins are strong inducers of IL-22: a potential role in atopic dermatitis. J Allergy Clin Immunol. 2010;126(6):6. 10.1016/J.JACI.2010.07.041

 

Comentarios

Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

AAIP RNBD
Términos y condiciones de uso | Política de privacidad | Todos los derechos reservados | Copyright 1997-2024